Long cycle-life wound lithium-ion battery cells having metallized film current collectors
US-2024358635-A1 · Oct 31, 2024 · US
US9687469B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9687469-B2 |
| Application number | US-201514835198-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 25, 2015 |
| Priority date | Nov 26, 2014 |
| Publication date | Jun 27, 2017 |
| Grant date | Jun 27, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A pharmaceutical composition for the prevention and treatment of cancer with specific flavanoid-based compounds selected from among the groups of Flavone, Flavanone and Flavanol, a method for the prevention and treatment of cancer and inflammation using the specific flavonoid-based pharmaceutical compositions, a method for isolating the flavonoid-based pharmaceutical compositions from raw plant material, and a method for synthesizing said specific flavonoid-based pharmaceutical compositions.
Opening claim text (preview).
We claim: 1. A flavonoid-based pharmaceutical composition for the selected from the group consisting of brain cancer, breast cancer, colon cancer, Kaposi sarcoma, leukemia, lung cancer, melanoma, oral and laryngeal cancer, ovarian cancer, pancreatic cancer, prostate cancer, stomach cancer, and thyroid cancer treatment of cancer and/or inflammation having a flavanone chemical structure of chemical formula 4: or any pharmaceutically acceptable salt thereof; wherein the group R1 may be an alkoxy group (O—CH3) a methoxy group (H3CO) or hydrogen, the groups R2 and R3 may each be a methoxy group (H3CO) or a hydroxy group (HO), the group R4 may be hydrogen, the groups R5, R7 and R10 are nothing, the group R6 may be an alkoxy group (O—CH3), a hydroxyl group (OH) or hydrogen, the group R8 may be an alkoxy group (O—CH3) or hydrogen, the group R9 may be a hydroxyl group (OH), halogen bromine (Br), chlorine (Cl), flourine (F), hydroxamic acid group (O2NH2HCl), amine (NH2), amide (R2N), or hydrogen; and wherein A and B may each be selected from the group consisting of: a single bond and a double bond.
with aryl radicals attached in position 2 · CPC title
3,4-Dihydrobenzopyrans, e.g. chroman, catechin · CPC title
2,3-Dihydro derivatives, e.g. flavanones · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.